| | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
---|
|
|
L | | IP | CI | | Tadalafil PAH OrPha 20 mg | 56 | 455.04 | 511.30 | 10 % | | Coated tablets: Tadalafilum 20 mg | OrPha Swiss GmbH | B / SL / SG | FB | | G |  |
L | | IP | CI | | Tadalafil PAH Spirig HC 20 mg | 56 | 455.04 | 511.30 | 10 % | | Coated tablets: Tadalafilum 20 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
L | | IP | CI | | Evenity 105 mg/1.17 ml | 2 | 439.49 | 494.40 | 10 % | | Injection solution in prefilled syringe: Romosozumabum 105mg / 1.17ml | UCB-Pharma SA | B / SL | FB | | G |  |
| | IP | CI | CM | Xylo Dexpanthenol Spirig HC | 10 ml | 1.79 | 3.30 | 10 % | | Nasal spray: 2 Active Agents | Spirig HealthCare AG | ● D / SL | FB | | G |  |
L | | IP | CI | | Pheburane 483 mg/g | | 430.03 | 484.10 | 10 % | | Granulat zur Herstellung einer Lösung zum Einnehmen: Natrii Phenylbutyras 483 mg | Medius AG | B / SL | FB | | G |  |
L | | IP | CI | | AJOVY 225 mg | 1.5 ml | 405.97 | 457.95 | 10 % | | Injektionslösung im Fertigpen: Fremanezumabum 225mg / 1.5ml | Teva Pharma AG | B / SL | FB | | G |  |
L | | IP | CI | | Besremi 250 μg / 0,5 ml | | 1505.56 | 1653.80 | 10 % | | Injektionslösung im Fertigpen: Ropeginterferonum Alfa-2b 250µg / 0.5ml | OrPha Swiss GmbH | A / SL | FB | | G |  |
L | | IP | CI | | Enspryng 120 mg | | 6682.56 | 7164.10 | 10 % | | Injektionslösung zur subkutanen Anwendung: Satralizumabum 120 mg/ml | Roche Pharma (Schweiz) AG | A / SL | FB | | G |  |
L | | IP | CI | | Lixim Patch | 7 | 13.17 | 24.30 | 10 % | | wirkstoffhaltiges Pflaster: Etofenamatum 70 mg | Drossapharm AG | D / SL | FB | | G |  |
| | IP | CI | | Dafalgan Extra 500 mg / 65 mg | 10 | PR | PR | k.A. | | Coated tablets: 2 Active Agents | UPSA Switzerland AG | D | FB | | G |  |
| | IP | CI | | Mavi Gynial | 21 | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Gynial AG | B | FB | | G |  |
| | IP | CI | | Mavi Gynial | 3 x 21 | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Gynial AG | B | FB | | G |  |
| | IP | CI | | Mavi Gynial | 6 x 21 | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Gynial AG | B | FB | | G |  |
| | IP | CI | | Tadalafil Spirig HC, 2.5 mg | 28 | PR | PR | k.A. | | Coated tablets: Tadalafilum 2.5 mg | Spirig HealthCare AG | B | FB | | G |  |
| | IP | | | Tadalafil Spirig HC, 5 mg | 28 | PR | PR | k.A. | | Coated tablets: Tadalafilum 5 mg | Spirig HealthCare AG | B | FB | | G |  |
| | IP | | | Tadalafil Spirig HC, 5 mg | 84 | PR | PR | k.A. | | Coated tablets: Tadalafilum 5 mg | Spirig HealthCare AG | B | FB | | G |  |
| | IP | | | Tadalafil Spirig HC, 10 mg | 4 | PR | PR | k.A. | | Coated tablets: Tadalafilum 10 mg | Spirig HealthCare AG | B | FB | | G |  |
| | IP | | | Tadalafil Spirig HC, 10 mg | 12 | PR | PR | k.A. | | Coated tablets: Tadalafilum 10 mg | Spirig HealthCare AG | B | FB | | G |  |
| | IP | | | Tadalafil Spirig HC, 10 mg | 24 | PR | PR | k.A. | | Coated tablets: Tadalafilum 10 mg | Spirig HealthCare AG | B | FB | | G |  |
| | IP | | | Tadalafil Spirig HC, 10 mg | 48 | PR | PR | k.A. | | Coated tablets: Tadalafilum 10 mg | Spirig HealthCare AG | B | FB | | G |  |
| | IP | | | Tadalafil Spirig HC, 20 mg | 4 | PR | PR | k.A. | | Coated tablets: Tadalafilum 20 mg | Spirig HealthCare AG | B | FB | | G |  |
| | IP | | | Tadalafil Spirig HC, 20 mg | 8 | PR | PR | k.A. | | Coated tablets: Tadalafilum 20 mg | Spirig HealthCare AG | B | FB | | G |  |
| | IP | | | Tadalafil Spirig HC, 20 mg | 12 | PR | PR | k.A. | | Coated tablets: Tadalafilum 20 mg | Spirig HealthCare AG | B | FB | | G |  |
| | IP | | | Tadalafil Spirig HC, 20 mg | 24 | PR | PR | k.A. | | Coated tablets: Tadalafilum 20 mg | Spirig HealthCare AG | B | FB | | G |  |
| | IP | CI | | AJOVY 225 mg | 3 x 1.5 ml | PR | PR | k.A. | | Injektionslösung im Fertigpen: Fremanezumabum 225mg / 1.5ml | Teva Pharma AG | B | FB | | G |  |
| | IP | | | Besremi 500 μg / 0,5 ml | | PR | PR | k.A. | | Injektionslösung im Fertigpen: Ropeginterferonum Alfa-2b 500µg / 0.5ml | OrPha Swiss GmbH | A | FB | | G |  |
| | IP | CI | | Carbaglu 200 mg | 5 | PR | PR | k.A. | | Tabletten zur Herstellung einer Suspension zum Einnehmen: Acidum Carglumicum 200 mg | Recordati AG | B | FB | | G |  |
| | IP | CI | | Carbaglu 200 mg | 60 | PR | PR | k.A. | | Tabletten zur Herstellung einer Suspension zum Einnehmen: Acidum Carglumicum 200 mg | Recordati AG | B | FB | | G |  |
| | IP | CI | | Lixim Patch | 2 x 7 | PR | PR | k.A. | | wirkstoffhaltiges Pflaster: Etofenamatum 70 mg | Drossapharm AG | D | FB | | G |  |